The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
November 30th 2024
Findings from PsABIOnd can help reassure clinicians of similar efficacy between treatment choices.
November 27th 2024
November 26th 2024
November 25th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
RA therapies in 2009: The latest on drug effectiveness
October 16th 2009Clinical study findings of recent years support the notion that patients with rheumatoid arthritis (RA) should be treated earlier and more aggressively. Monotherapy with disease-modifying antirheumatic drugs (DMARDs) is effective in some cases, but triple DMARD therapy is superior to double therapy or monotherapy in early or late RA. Leflunomide is at least as effective as methotrexate (MTX) and sulfasalazine and more effective than placebo.
Rooting Out Fraud Part 3: Billing Abuse by an Anesthesia Group
I was out of town on business and had a 'slip & fall.' After many tries and many hours on the phone, Oxford could not direct us to a plan orthopedist—hand surgeon? Yes; Foot and ankle? Didn't happen. Ironically (or was it?), that bureaucratic hurdle saved them a bundle.
Keeping acute rheumatic fever in the differential
October 4th 2009Acute rheumatic fever (ARF) was a major cause of morbidity and mortality in past decades, but with the passage of time and medical advances, it faded from the forefront of clinical medicine and, in turn, from physicians' minds. However, a resurgence of ARF has been reported in the United States and the condition remains a significant health concern in the developing world.
Identifying pleomorphic hyalinizing angiectatic tumor: A case report
October 3rd 2009A pleomorphic hyalinizing angiectatic tumor (PHAT) is a rare soft tissue lesion that mainly affects superficial soft tissue in the lower extremities. PHAT is classified as a borderline/intermediate-grade soft tissue tumor because of the substantial risk of local recurrence.
Did pay for performance pay off in England?
October 2nd 2009A pay-for-performance (P4P) scheme based on meeting targets for the quality of clinical care introduced to family practice in England in 2004 accelerated improvements in quality for 2 of 3 chronic conditions in the short term. However, the initial acceleration in improvement was not sustained.
MRI helps guide rotator cuff tear management
October 2nd 2009MRI may be used to monitor rotator cuff changes and guide management in long-term follow-up of patients with tears who are treated nonoperatively. Factors associated with tear progression include age older than 60 years, a full-thickness tear, and fatty infiltration of the rotator cuff muscles.
A healthy lifestyle lowers lifetime risk of heart failure in men
October 2nd 2009Adherence to healthy lifestyle factors is associated with a lower lifetime risk of heart failure in apparently healthy men compared with the general population. The lifetime risk is higher in men who have hypertension than in those who do not.
Remission after conventional treatment for RA is attainable
October 2nd 2009Sustained disease-modifying antirheumatic drug (DMARD)-free remission occurs in about 10% of patients with rheumatoid arthritis (RA). It can be predicted by several clinical variables that are assessed routinely in outpatient clinics.
Tumor necrosis factor inhibitors used for RA at lower threshold
October 2nd 2009Tumor necrosis factor (TNF) inhibitors are being used for rheumatoid arthritis (RA) more aggressively and at a lower level of disease activity than in the past. Their use is greater in patients with established RA than in those with early RA.
Prevent patellofemoral pain to prevent knee osteoarthritis?
October 2nd 2009Persons who have patellofemoral pain (PFP) exhibit higher peak levels of patellofemoral stress than those who do not, according to work conducted at the University of Southern California's Musculoskeletal Biomechanics Research Laboratory (MBRL), and a long-term history of PFP in older adults yields a higher probability that patellofemoral osteoarthritis (OA) will occur.
Musculoskeletal practice guidelines for general practitioners
September 30th 2009New evidence-based musculoskeletal disease prevention and treatment guidelines for general practitioners have been issued by the Royal Australian College of General Practitioners (RACGP). Rheumatoid arthritis (RA), juvenile idiopathic arthritis, and osteoarthritis guidelines have been released, and osteoporosis guidelines were expected to be available soon.
Signaling Molecules May Limit Bone Destruction and Bone Loss from RA
September 29th 2009Researchers have discovered a new way to use the role of signaling molecules to inhibit another complex that plays a key role in the ‘turning on’ of genes “that cause the stem cell precursors of osteoclasts to mature and start eating bone,” a discovery that may lead to the formation of new rheumatoid arthritis and osteoporosis drugs.
New Genetic Test Will Enable Early Detection - and Treatment - of Psoriatic Arthritis
September 16th 2009A new genetic test that can detect the presence of psoriatic arthritis (PsA) was launched on Tuesday, September 15, that may enable physicians to administer early treatment, lessening joint damage and decreasing inflammation, therefore reducing symptoms.
Stress in the Workplace may Decrease an Individual's Risk for Developing Rheumatoid Arthritis
September 10th 2009Psychosocial work stress has been previously associated with an increased risk for cardiovascular disease. New research now reveals that high work stress may actually decrease an individual's chance of developing inflammatory conditions, including rheumatoid arthritis.
Arthritis in a patient with severe psoriasis: Narrowing the differential
August 29th 2009An 84-year-old woman presented with pain and swelling in her knees and hands. She had a history of severe psoriasis and osteoarthritis. How can you make a differential diagnosis when OA may coexist with rheumatoid arthritis, psoriatic arthritis, OA, and crystal arthritis? Read on to find out.